GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vaidya Sane Ayurved Laboratories Ltd (NSE:MADHAVBAUG) » Definitions » Debt-to-Asset

Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Debt-to-Asset : 0.02 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Vaidyane Ayurved Laboratories Debt-to-Asset?

Vaidyane Ayurved Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹16.8 Mil. Vaidyane Ayurved Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹0.0 Mil. Vaidyane Ayurved Laboratories's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was ₹708.9 Mil. Vaidyane Ayurved Laboratories's debt to asset for the quarter that ended in Mar. 2024 was 0.02.


Vaidyane Ayurved Laboratories Debt-to-Asset Historical Data

The historical data trend for Vaidyane Ayurved Laboratories's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaidyane Ayurved Laboratories Debt-to-Asset Chart

Vaidyane Ayurved Laboratories Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Asset
Get a 7-Day Free Trial 0.21 0.04 0.02 - 0.02

Vaidyane Ayurved Laboratories Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only 0.02 - - 0.06 0.02

Competitive Comparison of Vaidyane Ayurved Laboratories's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Vaidyane Ayurved Laboratories's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaidyane Ayurved Laboratories's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vaidyane Ayurved Laboratories's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Vaidyane Ayurved Laboratories's Debt-to-Asset falls into.


;
;

Vaidyane Ayurved Laboratories Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Vaidyane Ayurved Laboratories's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Vaidyane Ayurved Laboratories's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vaidyane Ayurved Laboratories  (NSE:MADHAVBAUG) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Vaidyane Ayurved Laboratories Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Vaidyane Ayurved Laboratories's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Vaidyane Ayurved Laboratories Business Description

Traded in Other Exchanges
N/A
Address
201B, Bhoomi Velocity, Above ICICI Bank, Road No. 23, Wagle Estate, Thane (West), Thane, MH, IND, 400604
Vaidya Sane Ayurved Laboratories Ltd is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with traditional Ayurveda practices. It uses non-invasive, multidisciplinary, and therapies for treating chronic ailments. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management and knee pain relief. The company's business is divided into three segments i.e. Hospital Activity, Sale of Product and Common. It derives maximum revenue from Sale of Products.

Vaidyane Ayurved Laboratories Headlines

No Headlines